期刊文献+

宫颈癌患者凝血功能的检测及意义 被引量:11

Significance of indices of blood coagulation function in patients with cervical cancer
下载PDF
导出
摘要 目的研究宫颈癌患者止凝血功能指针的变化,了解宫颈癌患者凝血功能改变的意义。方法将78例宫颈癌患者按病理分期分为Ⅰ~Ⅱ期组(49例)、Ⅲ~Ⅳ期组(29例),采用SYSMEXCA-7000全自动血凝分析仪测定不同分期的宫颈癌患者和62例宫颈良性病变患者的凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)含量及D-二聚体(D-dimer)水平。结果宫颈癌患者的FIB、D-dimer水平与健康体检者和宫颈良性病变患者相比均显著增高,差异有统计学意义(P<0.01),而PT、TT、APTT水平差异无统计学意义(P>0.05)。肿瘤的恶性程度分期为Ⅲ~Ⅳ期患者血浆FIB、D-dimer水平均高于Ⅰ~Ⅱ期的患者,差异有统计学意义(P<0.05),而PT、TT、APTT在两组间差异无统计学意义(P>0.05)。结论宫颈癌患者常伴随凝血及纤溶功能异常改变,监测患者体内FIB、D-dimer的改变可作为预防血栓形成及慢性弥漫性血管内凝血等凝血性疾病的有效措施,且能为宫颈癌的病情进展与临床分期提供帮助。 Objective To explore the changes of blood coagulation indexes in the patients with cervical cancer for understanding their clinical significance.Methods PT、TT、APTT、FIB、D-dimer levels of 62 patients with benign cervical lesions and 78 cancer cervical patients including 49 pathological term ⅠtoⅡpatients and 29 pathological termⅢtoⅣpatients were detected by SYSMEX CA-7000.Results The level of FIB、D-dimer in the patients with cervical cancer were significantly higher than that in the patients with benign cervical lesions and physical examinees(P〈0.01) ,while there were no differences of PT、TT and APTT levels between the patients with cervical cancer and those in other two groups(P〉0.05) .In different period of cervical cancer,the level of plasma FIB、D-dimer of term ⅢtoⅣ were higher than that in termⅠtoⅡ(P〈0.05) ,while there were no significant differences of the level of PT、TT and APTT in the two groups(P〉0.05) .Conclusion The patients with cervical cancer are usually accompa-nied with dysfunction of blood coagulation and fibrinolytic systems,so monitoring their alterations in FIB、D-dimer levels could be a valid measure to prevent coagulation disorder and also useful for the diagnosis and clinical stage of cervical cancer.
作者 陈雪芹 张云
出处 《检验医学与临床》 CAS 2010年第21期2317-2318,共2页 Laboratory Medicine and Clinic
关键词 宫颈癌 凝血功能 凝血性疾病 cervical cancer blood coagulation function bloodfunction disease
  • 相关文献

参考文献7

  • 1Van Trappen PO,Gyselman VG,Lowe DG,et al.Molecular,quantification and mapping of lymPh-node micro-metastases in cervical cancer[J].Laneet,2001,357(9249):15-20.
  • 2Boccaccio C,Medico E.Cancer and blood coagulation[J].Cell Mol Life Sci,2006,63(9):1024-1027.
  • 3Rickles FR,Levine MN.Epidemicology of thrombosis in cancer[J].Acta Haematol,2002,106:6-12.
  • 4Wang X,Fu S,Freedman RS,et al.Venous thromboembolism syndrome in gynecological cancer[J].Int J Gynecol Cancer,2006,16:1458-1471.
  • 5郝栩婷,白玉柱,高阳.妇科肿瘤患者凝血功能变化及其临床意义[J].中国实验诊断学,2006,10(5):475-477. 被引量:12
  • 6王学锋,赵维莅,璩斌,程英,屠越峰,黄霞萍,王鸿利.肿瘤患者凝血及纤溶分子标志物变化[J].中华检验医学杂志,2000,23(6):331-333. 被引量:46
  • 7Samama MM,Horellou MH,Elalamy L,et al.D-dimer levels,connstitu tional thrombophilia,and venous thrombosis prediction:clinical aspects and implications[J].Semin Vasc Med,2005,5(4):371-374.

二级参考文献11

  • 1喇端端,陆静,华祖德.卵巢癌治疗前D-D二聚体及CA_(125)的检测[J].上海医学,1995,18(11):664-666. 被引量:13
  • 2Nands,Messmore H.Hemostasis in malignancy[J].Am J Haemato,1990,35(1):45.
  • 3FIGO committee report.FIGO staging for gestational trophoblastic neoplasia 2000 FIGO Oncology Committee[J].Int J Gynaecol Obstet,2002,77:285.
  • 4Masferrer JL,Leahy KM,Koki AT,et al.Antiangiogenic and anti-tumor activities of cyclooxygenase-2 inhibitors[J].Cancer Res,2000;60(5):1306.
  • 5Wada H,Sase T,Yamaguchi M.Hypercoagulant states in malignant lymphoma[J].Exp Oncol.2005 Sep;27(3):179.
  • 6Fibrin D-dimer and cardiovascular risk[J].Semin Vasc Med.2005 Nov;5(4):387.
  • 7Samama MM,Horellou MH,Elalamy I,et al.D-dimer levels,constitutional thrombophilia,and venous thrombosis prediction:clinical aspects and implications.Semin Vasc Med.2005 Nov;5(4):371.
  • 8Boisclair DA,Lane JT,Wilde HA.A Comparatire evaluatonn of markers of actived coagulation and/or fibrinolysis:thrombin antithrombin complex,D-dimer and Fibrinogen/Fibrin Fragment.Eantigen[J].Br J Haenatol,1990,74(4):471.
  • 9Gadducci A,et al.Pretreatment plasma levels of fibrinopeptide-A (FPA),D-dimer(DD),and Von Willebrano factor(VWF) in patients with ovarlan carcinoma[J].Gynecol oncol 1994,53:352.
  • 10张培彤,裴迎霞,朴炳奎,孙桂芝,林红生,祁鑫.肿瘤患者与正常人血小板表面粘附蛋白表达异同的临床观察及意义[J].中华肿瘤杂志,1998,20(3):207-209. 被引量:66

共引文献56

同被引文献90

引证文献11

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部